Updated:
Gene Capital
Gene Capital is a Beijing-based private equity firm focused on early-stage and growth venture investments across China and Asian technology markets.
Gene Capital
Gene Capital is a private equity firm based in Beijing, China. It focuses on venture capital investments.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Frequently asked questions
Who runs investment decisions at Gene Capital?
The firm does not publicly disclose its leadership or investment committee members. No named principals or managing partners are listed in public records.
How does Gene Capital source proprietary deal flow?
The firm likely relies on Beijing-based networks, industry relationships, and direct outreach to technology startups. No specific sourcing model is documented in public sources.
Is Gene Capital structured as a single family office or a private equity firm?
Public records classify Gene Capital as an asset manager and private equity firm, not a family office. Its exact legal structure is not publicly specified.
What investment stages does Gene Capital typically target?
The firm invests across early-stage rounds including seed, startup, and growth-stage financing. It covers the full venture capital lifecycle from initial funding to later-stage growth equity.
Does Gene Capital participate in fund commitments or only direct deals?
Based on available public information, Gene Capital appears to operate as a direct private equity investor rather than a fund-of-funds. No commitments to external funds have been publicly reported.
Which sectors does Gene Capital explicitly avoid?
The firm does not publicly disclose any excluded sectors. Its stated focus is on general venture and growth-stage technology investments.
Where does the underlying wealth come from?
The origin of Gene Capital's capital base is not publicly disclosed. It is not associated with any named family or corporate entity in public records.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: